WHO approves world’s-first Ebola vaccine

In a major step in the fight against Ebola, the World Health Organization (WHO) has approved the world’s first-ever vaccine against Ebola.

The drug, called Ervebo and manufactured by MERCK pharmaceuticals, was being used in an experimental phase in the Democratic Republic of Congo.

But now the WHO says there is sufficient evidence that shows that the vaccine works.

It means the world now has the first-ever drug to prevent Ebola.

A WHO prequalification is granted only after a drug passes important safety and efficacy tests.

But this vaccine has already been in use since last year to contain two outbreaks in the Democratic Republic of Congo.

The government invoked “compassionate protocols” to allow its use while research was still underway.

The evidence collected during that time has convinced regulators that it was safe and effective against Ebola.

The vaccine will be available in the market from around mid-next year.


(Visited 76 times, 1 visits today)
About Cholo Brooks 14001 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.